About Us

Powered by 20+ years of biotech research Murnia™ team aims to prevent, protect and treat everyday to severe conditions of mucosa and skin using patented molecular compound, unique patented formulas and always using clean ingredients for effective and responsible solutions.

Innovation to prevent severe cancer wounds

Murnia™ started with a focus on severe cancer wounds, side effect of toxic treatments. Powered by innovative molecular compound, Murnia™ solutions have demonstrated strong prevention effects in trials presented at international oncology congresses.

ORAL MUCOSITIS - Double Blind Placebo Controlled Clinical Trial (H&N Cancer Patients)

  • No Grade 3/4 progression in Murnia cohort.
  • No break in treatment.
  • No opioids or side effects. 

RADIODERMATITIS Observational Study - (Radiotherapy Patients)

  • <12% progression to Grade 3, a significant reduction. 
Download e-poster

Awards

Patented MURNIA™ Molecular Compound

  • Adhesive properties
  • Rich in sesquiterpens known for pain soothing effect.
  • Tested antimicrobial, antiviral, anti-fungal properties.
  • 69% antioxidant effect (ROS Scavenging)
  • Shown to support skin's natural regenerative process with  essential elements like Collagen, Elastin, TGFβ1, HAS3.
Learn more

Portfolio of Solutions with Patented Molecular Compound.

Murnia™ Molecular Compound is integrated into a variety of formulations for different oral mucosal and skin conditions.

Only, Murnia™ Mouth Spray is available in the US.

Other solutions to help a variety of needs in development and available in Europe are: 

  • Mouth Gel - to help with ulcerations and oral wounds.
  • Recovery Cream - to help with dermatitis.
  • Dermal Solutions - leveraging the anti-aging properties of compound.